Fonte: Journal of Inorganic Biochemistry. Unidades: IFSC, FFCLRP
Assuntos: NEOPLASIAS, CRISTALOGRAFIA, COMPOSTOS INORGÂNICOS
ABNT
FERNÁNDEZ, Carlos Y. et al. Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer. Journal of Inorganic Biochemistry, v. No 2024, p. 112700-1-112700-8 + supplementary data, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.jinorgbio.2024.112700. Acesso em: 18 nov. 2024.APA
Fernández, C. Y., Alvarez, N., Rocha, A., Mendes, L. F. S., Costa Filho, A. J. da, Ellena, J., et al. (2024). Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer. Journal of Inorganic Biochemistry, No 2024, 112700-1-112700-8 + supplementary data. doi:10.1016/j.jinorgbio.2024.112700NLM
Fernández CY, Alvarez N, Rocha A, Mendes LFS, Costa Filho AJ da, Ellena J, Batista AA, Facchin G. Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer [Internet]. Journal of Inorganic Biochemistry. 2024 ; No 2024 112700-1-112700-8 + supplementary data.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.jinorgbio.2024.112700Vancouver
Fernández CY, Alvarez N, Rocha A, Mendes LFS, Costa Filho AJ da, Ellena J, Batista AA, Facchin G. Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer [Internet]. Journal of Inorganic Biochemistry. 2024 ; No 2024 112700-1-112700-8 + supplementary data.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.jinorgbio.2024.112700